You have 9 free searches left this month | for more free features.

Prophylatic antiviral agents

Showing 1 - 25 of 7,288

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Clinical Trials of Investigational or Licensed Vaccines or

Recruiting
  • Vaccines
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Diabetes, Hepatitis C, Chronic, Cardiovascular Diseases Trial run by the National Institute of Diabetes and Digestive and Kidney

    Recruiting
    • Diabetes Mellitus
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 27, 2023

    Chronic Hepatitis B Trial in Seoul (Standard of care)

    Active, not recruiting
    • Chronic Hepatitis B
    • Standard of care
    • Seoul, Korea, Republic of
    • +3 more
    Mar 29, 2023

    Treatment of Hepatitis c by Using Direct-acting Antiviral

    Not yet recruiting
    • Hepatitis C
    • Direct Acting Antivirals
    • (no location specified)
    May 9, 2022

    TURN-COVID Biobank: The Dutch Cohort Study for Evaluation of Use

    Recruiting
    • COVID-19
    • casirivimab with imdevimab
    • +2 more
    • Amsterdam, Noord Holland, Netherlands
    • +3 more
    Jan 13, 2022

    COVID-19 International Drug Pregnancy Registry

    Recruiting
    • Covid19
    • Antiviral Agents
    • Monoclonal antibody
    • Los Angeles, California
      Pregistry
    Jul 20, 2022

    COVID-19 Trial in Sao Paulo (Atazanavir, Daclatasvir 60 mg, Sofusbuvir + Daclastavir 60 mg)

    Active, not recruiting
    • COVID-19
    • Sao Paulo, SP, Brazil
      Hospital do Coracao
    Feb 25, 2022

    HIV Trial in Roma (Antiviral Agents)

    Not yet recruiting
    • HIV Infections
    • Antiviral Agents
    • Roma, Italy
      Fondazione PoliclinicoAgostino Gemelli IRCCS
    Feb 9, 2023

    Direct-acting Antiviral Agents on HCV Cognitive Function, and

    Recruiting
    • Depression in Chronic Hepatitis C
    • Depression and Cognitive Tests
    • Chandigarh, India
      Postgraduate Institute of Medical Education and Research
    Sep 26, 2021

    Monkeypox, Antiviral Agents Trial in Brazil, Switzerland (Tecovirimat, Placebo)

    Not yet recruiting
    • Monkeypox
    • Antiviral Agents
    • Belo Horizonte, Brazil
    • +8 more
    Oct 28, 2022

    Steatohepatitis in Chronic Hepatitis B

    Completed
    • Fatty Liver
    • Chronic Hepatitis b
    • Antiviral Agents
    • Bangkoknoi, Bangkok, Thailand
      Faculty of Medicine Siriraj Hospital
    Mar 30, 2022

    Hepatitis B Reactivation, Hematopoietic Stem Cell Transplantation, Antiviral Drug Trial in Seoul (Entecavir)

    Enrolling by invitation
    • Hepatitis B Reactivation
    • +3 more
    • Seoul, Korea, Republic of
      Jeong Won Jang
    Dec 16, 2022

    Effect of DAAs on Behavior of HCC in HCV Patients

    Completed
    • Carcinoma, Hepatocellular
    • Hepatitis C
      • Cairo, Egypt
      • +2 more
      Jul 19, 2021

      Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in United States (CYNK-001)

      Recruiting
      • Leukemia
      • +19 more
      • CYNK-001
      • Denver, Colorado
      • +9 more
      Sep 9, 2022

      Follow up of IFN Vs DAAs HCV SVR (IFDACS Study)

      Recruiting
      • Chronic Hepatitis C Infection
        • Beijing, Beijing, China
        • +2 more
        Aug 27, 2021

        Covid19, Pneumonia, Viral Trial in Hannibal (alpha1-proteinase inhibitor, Antiviral Agents)

        Withdrawn
        • Covid19
        • Pneumonia, Viral
        • alpha1-proteinase inhibitor
        • Antiviral Agents
        • Hannibal, Missouri
          Blessing Corporate Services, Inc
        Dec 17, 2020

        Chronic Hepatitis C Infection Trial in Beijing, Hong Kong (PR4 + LDV/SOF + ASV 4 wk, PR4 + LDV/SOF + SMV 4 wk, PR4 + LDV/SOF +

        Recruiting
        • Chronic Hepatitis C Infection
        • PR4 + LDV/SOF + ASV 4 wk
        • +7 more
        • Beijing, Beijing, China
        • +1 more
        Aug 27, 2021

        Different Antiviral Regimens for Hepatitis C Virus Relapse

        Unknown status
        • Hepatitis C
        • +2 more
        • directly acting antivirals
        • Alexandria, Egypt
          Alexandria University.
        Dec 4, 2020

        Chronic Hepatitis C Infection, HBV Coinfection, Hepatitis B Reactivation Trial in Hong Kong (Ledipasvir/Sofosbuvir, Sofosbuvir

        Completed
        • Chronic Hepatitis C Infection
        • +2 more
        • Hong Kong, Hong Kong, China
          Humanity and Health GI and Liver Centre
        Aug 27, 2021

        Hepatitis C Under Treatment With Antiviral Agents

        Completed
        • Glucose Metabolism Disorders
        • +2 more
        • Lab tests, non-invasive fibrosis (Fibroscan/ARFI)
        • Frankfurt am Main, Germany
          Klinikum der J. W. Goethe-Universität
        Jul 20, 2020

        COVID-19 Trial in Assiut (Licorice extract)

        Completed
        • COVID-19
        • Licorice extract
        • Assiut, Egypt
          Faculty of Medicine, Assiut University
        Mar 21, 2022

        Periodontitis Chronic Generalized Severe Trial in Nice, Marseille, Rennes (Antiviral treatment with conventional non-surgical

        Not yet recruiting
        • Periodontitis Chronic Generalized Severe
        • Antiviral treatment with conventional non-surgical treatment
        • Placebo with conventional non-surgical treatment
        • Nice, Alpes Maritimes, France
        • +2 more
        Jun 5, 2023

        Occult Hepatitis C Virus Infection in Patients Born Before 1969

        Not yet recruiting
        • Hepatitis C, Chronic
        • +2 more
        • Meridan Bioscience Point of Care test against HCV antibodies
        • (no location specified)
        Apr 2, 2023

        HCV RAS Testing in Public Health Programs

        Unknown status
        • Hepatitis C
        • +3 more
        • Direct Acting Antivirals
        • Chandigarh, India
        • +1 more
        Jan 22, 2020

        After Long-Term Antiviral Treatment for Chronic Hepatitis B

        Completed
        • Chronic Hepatitis B e Antigen Positive
        • Chronic Hepatitis B e Antigen Negative
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Jan 26, 2023